These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3755560)

  • 1. Haemodynamic role of vasopressin released during Finnish sauna.
    Bussien JP; Gaillard RC; Nussberger J; Waeber B; Hofbauer KG; Turnill D; Brögger R; Brunner HR
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):166-71. PubMed ID: 3755560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies with a vascular vasopressin antagonist.
    Waeber B; Nussberger J; Hofbauer KG; Nicod P; Brunner HR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S111-6. PubMed ID: 2434764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of vasopressin in cardiovascular and neurohormonal responses to intracerebroventricular hypertonic NaCl.
    Kawano Y; Ferrario CM
    Jpn Heart J; 1990 Mar; 31(2):237-44. PubMed ID: 1972413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
    Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
    Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure].
    Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR
    Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the vascular effect of vasopressin in patients with mild essential hypertension.
    Bussien JP; Waeber B; Nussberger J; Hofbauer KG; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):130-9. PubMed ID: 3767522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin blood flow reduction induced by cigarette smoking: role of vasopressin.
    Waeber B; Schaller MD; Nussberger J; Bussien JP; Hofbauer KG; Brunner HR
    Am J Physiol; 1984 Dec; 247(6 Pt 2):H895-901. PubMed ID: 6548876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
    Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic response to vasopressin in dehydrated human subjects.
    Huch KM; Wall BM; Mangold TA; Bobal MA; Cooke CR
    J Investig Med; 1998 Aug; 46(6):312-8. PubMed ID: 9737094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in hormones reflecting sympathetic activity in the Finnish sauna.
    Lammintausta R; Syvälahti E; Pekkarinen A
    Ann Clin Res; 1976 Aug; 8(4):266-71. PubMed ID: 999213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does vasopressin sustain blood pressure of normally hydrated healthy volunteers?
    Bussien JP; Waeber B; Nussberger J; Schaller MD; Gavras H; Hofbauer K; Brunner HR
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H143-7. PubMed ID: 6364837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral regulation of blood flow to choroid plexus: role of arginine vasopressin.
    Faraci FM; Mayhan WG; Farrell WJ; Heistad DD
    Circ Res; 1988 Aug; 63(2):373-9. PubMed ID: 3396158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers.
    Vanakoski J; Seppälä T
    Eur J Clin Pharmacol; 1995; 48(2):133-7. PubMed ID: 7589027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular effects of arginine vasopressin, angiotensin II, and norepinephrine in adrenal insufficiency.
    Ishikawa S; Schrier RW
    Am J Physiol; 1984 Jan; 246(1 Pt 2):H104-13. PubMed ID: 6364835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
    Stone CK; Liang CS; Imai N; Sakamoto S; Sladek CD; Hood WB
    Circulation; 1988 Nov; 78(5 Pt 1):1251-9. PubMed ID: 3180381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.
    Nicod P; Biollaz J; Waeber B; Goy JJ; Polikar R; Schlapfer J; Schaller MD; Turini GA; Nussberger J; Hofbauer KG
    Br Heart J; 1986 Nov; 56(5):433-9. PubMed ID: 3790379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of vasopressin in renal vascular changes with hypoxemia and hypercapnic acidosis in conscious dogs.
    Rose CE; Ragsdale NV; Carey RM
    Am J Physiol; 1990 Oct; 259(4 Pt 2):R690-702. PubMed ID: 2145777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular effects of arginine vasopressin during fluid deprivation in the rat.
    Aisenbrey GA; Handelman WA; Arnold P; Manning M; Schrier RW
    J Clin Invest; 1981 Apr; 67(4):961-8. PubMed ID: 7204578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C; Haywood JR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin.
    Puurunen J; Leppäluoto J
    Eur J Pharmacol; 1984 Sep; 104(1-2):145-50. PubMed ID: 6094207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.